Myleran and graft versus host disease Patient Reports February 11, 2012



Myleran Side Effects Report #4633883-0
Myleran side effect was reported by a Consumer or non-health professional from on Apr 01, 2005. Male patient, 67 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: aspergillosis, graft dysfunction, graft versus host disease. Myleran dosage: 4 MG/KG/VARIABLE DOSE/ UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTIHYMOCYTE IG, GRANULOCYTE COL. Patient died.

Myleran Side Effects Report #4633878-7
Myleran side effect was reported by a Consumer or non-health professional from on Apr 01, 2005. Male patient, 38 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: graft versus host disease. Myleran dosage: 4 MG/KG/ VARIABLE DOSE. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IG, GRANULOCYTE COL. Patient died.

Myleran Side Effects Report #4607695-8
Myleran side effect was reported by a Consumer or non-health professional from on Feb 21, 2005. Female patient, 14 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: accidental overdose, convulsion, cytomegalovirus infection What is  cytomegalovirus infection, graft versus host disease, hyperbilirubinaemia, multi-organ failure, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IG. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Myleran